Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Zydus Cadila gets USFDA nod for its ulcerative colitis drug

      Zydus Cadila gets USFDA nod for its ulcerative colitis drug

      Ruby Khatun Khatun27 July 2017 9:15 AM IST
      New Delhi: Drug firm Zydus Cadila on Tuesday said it has received final approval from US health regulator for generic Mesalamine delayed-release...
      Sandoz expands partnership with World Child Cancer, to help children access treatment in four developing countries

      Sandoz expands partnership with World Child Cancer, to help children access treatment in four developing countries

      Ruby Khatun Khatun27 July 2017 9:14 AM IST
      Holzkirchen: Sandoz announces the expansion of a pilot project with leading charity World Child Cancer, aimed at improving access to treatment and...
      FIR against 37 hospitals for reusing medical devices meant for single use

      FIR against 37 hospitals for reusing medical devices meant for single use

      Ruby Khatun Khatun27 July 2017 9:00 AM IST
      Mumbai: Shocked by the reuse of one time use medical devices and overcharging by many hospitals on the same, the Maharashtra Government has announced...
      Govt recovers Rs 238.84 crore from drug makers for overcharging

      Govt recovers Rs 238.84 crore from drug makers for overcharging

      Ruby Khatun Khatun26 July 2017 9:30 AM IST
      New Delhi: Government has so far recovered an amount of Rs 238.84 crore as fine from pharmaceutical companies for overcharging, Parliament was...
      Lupin gets USFDA nod to market solution for skin conditions

      Lupin gets USFDA nod to market solution for skin conditions

      Ruby Khatun Khatun26 July 2017 9:22 AM IST
      New Delhi: Drug firm Lupin on Monday said it has received final approval from the US health regulator to market its Fluocinonide topical solution used...
      Delhi government tells Philip Morris to remove all ads

      Delhi government tells Philip Morris to remove all ads

      Ruby Khatun Khatun26 July 2017 9:20 AM IST
      New Delhi: Delhi government told Philip Morris International Inc and other tobacco companies on Saturday to remove all advertisements from tobacco...
      Merck gets USFDA Tentative Approval for Biologic Insulin

      Merck gets USFDA Tentative Approval for Biologic Insulin

      Ruby Khatun Khatun26 July 2017 9:20 AM IST
      KENILWORTH, N.J.: Merck, known as MSD outside of the United States and Canada, announced that the U.S. Food and Drug Administration(FDA) has granted...
      Pfizer, Merck KGaA skin cancer drug gets EMA nod for approval

      Pfizer, Merck KGaA skin cancer drug gets EMA nod for approval

      Ruby Khatun Khatun26 July 2017 9:19 AM IST
      European regulators on Friday recommended approving Pfizer Inc and Merck KGaA's immuno-oncology drug Bavencio to treat a rare type of skin cancer...
      Cipla launches anti-malaria drug for young children

      Cipla launches anti-malaria drug for young children

      Ruby Khatun Khatun26 July 2017 9:15 AM IST
      New Delhi: Drug major Cipla in partnership with Medicines for Malaria Venture (MMV) launched a drug used for the treatment of severe malaria in young...
      Amgen And Array BioPharma Announce Preclinical License And Collaboration Agreement In Inflammation

      Amgen And Array BioPharma Announce Preclinical License And Collaboration Agreement In Inflammation

      Ruby Khatun Khatun26 July 2017 9:15 AM IST
      THOUSAND OAKS, Calif. and BOULDER: Amgen and Array BioPharma announced a collaboration agreement for the discovery and development of novel drugs for...
      Follow notification on capping prices of stents: Health ministry to hospitals

      Follow notification on capping prices of stents: Health ministry to hospitals

      Ruby Khatun Khatun25 July 2017 10:15 AM IST
      New Delhi: The Ministry of Health has directed all hospitals including privates ones to follow its February notification on capping the prices of...
      KKR to buy WebMD in Rs 18,000 crore deal

      KKR to buy WebMD in Rs 18,000 crore deal

      Ruby Khatun Khatun25 July 2017 10:00 AM IST
      Online health publisher WebMD Health Corp said on Monday it agreed to be bought by private equity firm KKR & Co in a deal valued at about $2.8...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok